Treatment of progressive metastatic glomus jugulare tumor (paraganglioma) with gemcitabine

J M Pipas; R F Krywicki

doi:10.1093/neuonc/2.3.190

Treatment of progressive metastatic glomus jugulare tumor (paraganglioma) with gemcitabine

Neuro Oncol. 2000 Jul;2(3):190-1. doi: 10.1093/neuonc/2.3.190.

Authors

J M Pipas¹, R F Krywicki

Affiliation

¹ Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.

Abstract

Paragangliomas are rare tumors of the paraganglia composed of specialized neural crest cells arising in association with sympathetic ganglia. Here we report a case of progressive, metastatic paraganglioma (glomus jugulare tumor) responsive to single agent gemcitabine. In addition, a brief review of chemotherapy for paraganglioma follows the case presentation.

Publication types

Case Reports

MeSH terms

Adolescent
Antimetabolites, Antineoplastic / therapeutic use*
Brain Neoplasms / diagnosis
Brain Neoplasms / pathology*
Deoxycytidine / analogs & derivatives
Deoxycytidine / therapeutic use*
Female
Gemcitabine
Humans
Lung Neoplasms / diagnosis
Lung Neoplasms / drug therapy*
Lung Neoplasms / secondary*
Magnetic Resonance Imaging
Paraganglioma / diagnosis
Paraganglioma / drug therapy*
Paraganglioma / secondary*
Tomography, X-Ray Computed

Substances

Antimetabolites, Antineoplastic
Deoxycytidine
Gemcitabine